The adverse influence of pretransplant interferon-α (IFN-α) on transplant outcome after marrow transplantation for chronic phase chronic myelogenous leukemia increases with the duration of IFN-α exposure

被引:14
作者
Beelen, DW [1 ]
Elmaagacli, AH [1 ]
Schaefer, UW [1 ]
机构
[1] Univ Hosp Essen, Dept Bone Marrow Transplantat, Essen, Germany
关键词
D O I
10.1182/blood.V93.5.1779.405a39b_1779_1781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1779 / 1780
页数:2
相关论文
共 2 条
[1]   PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME [J].
BEELEN, DW ;
GRAEVEN, U ;
ELMAAGACLI, AH ;
NIEDERLE, N ;
KLOKE, O ;
OPALKA, B ;
SCHAEFER, UW .
BLOOD, 1995, 85 (10) :2981-2990
[2]   Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase [J].
Morton, AJ ;
Gooley, T ;
Hansen, JA ;
Appelbaum, FR ;
Bruemmer, B ;
Bjerke, JW ;
Clift, R ;
Martin, PJ ;
Petersdorf, EW ;
Sanders, JE ;
Storb, R ;
Sullivan, KM ;
Woolfrey, A ;
Anasetti, C .
BLOOD, 1998, 92 (02) :394-401